Originally published : Wed, Apr 01, 2020 @ 09:27 AM
Back in September 2018, LGC acquired Lucigen Corporation. The ISO accredited site is based in Middleton, Wisconsin and employs just over 75 people. Lucigen specialises in enzymes, competent cells, and cloning systems to support applications in diagnostics, drug discovery, synthetic biology and gene editing, and now as a part of the Biosearch Technologies portfolio, is expanding next generation sequencing (NGS) services in support of our agricultural biotechnology customers.
While we have been providing sequencing services out of our Berlin site for over a decade, we are excited to expand our reach with a new service lab in the US to better streamline orders and processing to support an increasing global demand for targeted NGS in agrigenomics. Some immediate improvements will include:
Faster turnaround times
More efficient flow of samples and data for faster results
Extended technical support
More agribusinesses are realising the power of NGS, but their research teams are challenged by the complexities and costs of the many techniques available. Industry leaders choose to outsource to us for simplified workflows while keeping high costs at bay.
LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.